Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Luna Fit
Alinwell review
A GLP-1 program that markets itself to women and prices itself to new arrivals: the $149 every page advertises is a first-month rate, and the standing $249 shows up nowhere until the checkout at the end of a thirty-screen intake.
- Semaglutide
- $249/mo month-to-month ($149 is the first month only — the checkout strikes $249 beside it); prepay $219/mo for three months or $189/mo for six
- Tirzepatide
- $299/mo month-to-month ($199 first month only); prepay $269/mo for three months or $239/mo for six
- Coverage
- All 50 states and DC in its own intake selector; no state list is published
- Brand-name
- Compounded only
The Luna Fit scorecard
Alinwell scored on our six women's-health factors. See the methodology.
What we like
- Names four dispensing pharmacies with street addresses in certificates of analysis its own treatment pages link, each with a third-party assay report attached
- Both molecules plus a microdose tier and a daily oral option, so the route can change without changing provider
- The monthly plan is genuinely month-to-month at checkout — no prepay is required to reach the standard rate
- Flat-rate copy is specific rather than vague: no consultation charge, no dose-change surcharge, and a dietitian visit inside the price
- Publishes a working phone number, clinical hours and a clinic address in Southlake, Texas
- Asks about pregnancy, breastfeeding and plans to conceive at the fifth question, before it takes a weight
The caveats
- Every figure the public site shows is a first-month rate — $149 and $199 are struck through against $249 and $299 at checkout
- The three-month plan it labels most popular costs more per month than the advertised monthly figure, because that figure is an introductory one
- No price of any kind appears in the first thirty screens; the ladder arrives only after name, email, phone and address are collected
- Three incompatible cancellation rules are published at once — forty-eight hours' notice, thirty days' notice, and cancel anytime with no contracts
- The mailing address on both legal pages is unedited template text reading "123 Example Street, Suite 100, Your City, WI, 92308"
- No clinician is named anywhere, no NPI, no medical group, and no 503A or 503B pharmacy class is stated
- Sells no hormone, PCOS or menopause care at all — the women's framing is positioning rather than a clinical service
- Announces that you are approved before a clinician has read the file, beside a countdown that resets every time the page reloads
The bottom line
Best for: Women who want a woman-facing program with both molecules, a microdose tier and a needle-free route — and who will read the checkout closely enough to budget against $249, not $149. A GLP-1 program that markets itself to women and prices itself to new arrivals: the $149 every page advertises is a first-month rate, and the standing $249 shows up nowhere until the checkout at the end of a thirty-screen intake.
Ranked #65 of 71 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Cancellation fairness is where Alinwell scores lowest, at 48/100. If that is your sticking point, start with what women pick instead of Alinwell.
Others in Alinwell's score range
The providers scoring closest to Alinwell on the same six factors. One of those comparisons is written out in full: the Alinwell–CoreAge Rx head-to-head, 22 points apart on the Luna Fit Score. Directly below Alinwell sits MyFastRx at #66 with 68/100 — see what women pick instead of MyFastRx if that is the band you are shopping in.
See all 71 providers we've reviewed for women — ranked on the same rubric, with scores and pricing side by side.
Pricing, states and verification reflect Alinwell's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on Alinwell's site. Not medical advice; see our disclosure.